 - To characterize changes in the blood levels of plasminogen activator inhibitor-1 PAI-1 and tissue type plasminogen activator t-PA across the 24 hour cycle in patients with obstructive sleep apnea, as compared to normal controls, and to further identify the pattern of changes with varying severity of obstructive sleep apnea, and 